Stock NVCT NUVECTIS PHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Nuvectis Pharma, Inc.

Equities

NVCT

US67080T1088

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/05/2024 BST 		5-day change 1st Jan Change
6.58 USD +5.96% Intraday chart for Nuvectis Pharma, Inc. +8.22% -21.10%
05-07 Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-08 Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines CI

Evolution of the average Target Price on Nuvectis Pharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

aa39f99a8cae06d628a7904fc.GGIL1LUGzDjI1EGNjzfGiwZHBheW6bO8BDvVnY6I6Q4.WgFfkPlXvVT9rCL5uVuvulk_MWPdoNGRfmyP0urpiEpTJV64_3aPW6XsAA~05b14e228d3cfe88eccf1d53bd4dabac

Analyst Recommendations on Nuvectis Pharma, Inc.

Ladenburg Thalmann Initiates Nuvectis Pharma at Buy with $21 Price Target MT
HC Wainwright Initiates Nuvectis Pharma at Buy With $14 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
6.58 USD
Average target price
22 USD
Spread / Average Target
+234.35%
High Price Target
25 USD
Spread / Highest target
+279.94%
Low Price Target
20 USD
Spread / Lowest Target
+203.95%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nuvectis Pharma, Inc.

Ladenburg Thalmann
HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. NVCT Stock
  4. Consensus Nuvectis Pharma, Inc.